Caxton Associates LP X Biotech Inc. Transaction History

Caxton Associates LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.13 - $9.2 $52,885 - $94,842	-10,309 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$15.92 - $20.3 $164,119 - $209,272	10,309 New	10,309 $177,000
Q3 2020 Nov 16, 2020	SELL	$13.97 - $21.16 $401,847 - $608,667	-28,765 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$10.39 - $16.07 $298,868 - $462,253	28,765 New	28,765 $394,000
Q1 2020 May 15, 2020	SELL	$8.89 - $24.94 $124,504 - $349,284	-14,005 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.33 - $19.95 $116,661 - $279,399	14,005 New	14,005 $261,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $124M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.